TY - JOUR
T1 - Macromolecular Synthesis following a Single Application of Polycyclic Hydrocarbons Used as Initiators of Mouse Skin Tumorigenesis
AU - Slaga, T. J.
AU - Bowden, G. T.
AU - Shapas, B. G.
AU - Boutwell, R. K.
PY - 1974/4
Y1 - 1974/4
N2 - After the application of initiating doses of polycyclic aromatic hydrocarbons, the incorporation of thymidine-3H, cytidine-3H, and leucine-3H into DNA, RNA, and protein, respectively, in mouse skin epidermis was determined. Parallel histological changes were correlated. A single initiating dose (0.05 or 0.10 μmole) of 7, 12-dimethylbenz[a]anthracene depressed DNA synthesis for 24 hr without a subsequent increase; there was no detectable epidermal hyperplasia, nor was RNA or protein synthesis altered. In contrast, 7, 12-dimethylbenz[a]anthracene applied in sufficient quantity to result in tumor formation after a single dose (0.6 or 1.2 μmoles) caused a larger and more protracted inhibition of DNA synthesis, followed by a gradual increase above control level. Inflammation was evident at 6 days and, by 10 days after treatment, some visible wounding was observed and RNA and protein synthesis were stimulated. Initiating doses of 1, 2, 5, 6-dibenz[a]anthracene gave results similar to initiating doses of DMBA; there was an early inhibition in DNA synthesis that was not followed by a stimulation. 1, 2, 3, 4-Dibenzanthracene, a weak or inactive initiating agent, produced a large peak of RNA synthesis at Day 1, but DNA synthesis was close to control values at all times studied and, histologically, the skin sections appeared normal. 7, 12-Dimethylbenz[a]anthracene, applied to skin in which DNA synthesis was stimulated 3-fold by acetic acid, blocked the increased incorporation of thymidine-3H into DNA.
AB - After the application of initiating doses of polycyclic aromatic hydrocarbons, the incorporation of thymidine-3H, cytidine-3H, and leucine-3H into DNA, RNA, and protein, respectively, in mouse skin epidermis was determined. Parallel histological changes were correlated. A single initiating dose (0.05 or 0.10 μmole) of 7, 12-dimethylbenz[a]anthracene depressed DNA synthesis for 24 hr without a subsequent increase; there was no detectable epidermal hyperplasia, nor was RNA or protein synthesis altered. In contrast, 7, 12-dimethylbenz[a]anthracene applied in sufficient quantity to result in tumor formation after a single dose (0.6 or 1.2 μmoles) caused a larger and more protracted inhibition of DNA synthesis, followed by a gradual increase above control level. Inflammation was evident at 6 days and, by 10 days after treatment, some visible wounding was observed and RNA and protein synthesis were stimulated. Initiating doses of 1, 2, 5, 6-dibenz[a]anthracene gave results similar to initiating doses of DMBA; there was an early inhibition in DNA synthesis that was not followed by a stimulation. 1, 2, 3, 4-Dibenzanthracene, a weak or inactive initiating agent, produced a large peak of RNA synthesis at Day 1, but DNA synthesis was close to control values at all times studied and, histologically, the skin sections appeared normal. 7, 12-Dimethylbenz[a]anthracene, applied to skin in which DNA synthesis was stimulated 3-fold by acetic acid, blocked the increased incorporation of thymidine-3H into DNA.
UR - http://www.scopus.com/inward/record.url?scp=0016054976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016054976&partnerID=8YFLogxK
M3 - Article
C2 - 4814994
AN - SCOPUS:0016054976
VL - 34
SP - 771
EP - 777
JO - Journal of Cancer Research
JF - Journal of Cancer Research
SN - 0008-5472
IS - 4
ER -